by admin, Author at Intelacia

The resurgence of biopharma M&A in 2025 marked one of the most decisive strategic shifts the life...

Portable ECMO is rapidly reshaping critical care delivery, and the surge in wearable-medical device patents shows how...

The rise of GLP‑1 therapies has reshaped the management of obesity and metabolic disease, yet a growing...

The NVIDIA Groq deal is a landmark strategic transaction reportedly valued at $20 billion representing a watershed...

Understanding fine-tuning risks in AI models and IP in AI systems is essential for any organization deploying...

Meta Platforms’ latest update to its Meta AI Glasses marks a turning point in how we think...

Innovation in cancer research has always been driven by a central challenge: how to intervene in complex...

Explore how cellular regeneration through stem cell research and nanotechnology may restore mitochondrial energy and redefine regenerative...

In March 2025, NewHydrogen, Inc., in partnership with the University of California, Santa Barbara (UCSB), filed a...

A Global Challenge: PFAS Pollution Per- and polyfluoroalkyl substances (PFAS) are among the most persistent and hazardous...

1 2 3 4 5